[{"NetIncomeLoss_1_Q1_USD":3121000.0,"InterestPaidNet_1_Q1_USD":593000.0,"InventoryFinishedGoods_0_Q1_USD":348000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":1764000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":30054000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-158000.0,"AssetsCurrent_0_Q1_USD":228132000.0,"DerivativeGainLossOnDerivativeNet_1_Q1_USD":25016000.0,"DilutiveSecurities_1_Q1_USD":-25016000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":892000.0,"SellingAndMarketingExpense_1_Q1_USD":8086000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":2999716.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":1197000.0,"ConvertibleDebtNoncurrent_0_Q1_USD":24822000.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"CommonStockSharesIssued_0_Q1_shares":76236710.0,"Assets_0_Q1_USD":243040000.0,"ShareBasedCompensation_1_Q1_USD":3086000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":5617000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AccruedLiabilitiesCurrent_0_Q1_USD":13574000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"GeneralAndAdministrativeExpense_1_Q1_USD":7665000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"IncomeTaxExaminationPenaltiesAndInterestAccrued_0_Q1_USD":0.0,"ResearchAndDevelopmentExpense_1_Q1_USD":10927000.0,"InventoryRawMaterials_0_Q1_USD":373000.0,"EarningsPerShareBasic_1_Q1_USD":0.04,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":87245706.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-1111000.0,"AccountsReceivableNetCurrent_0_Q1_USD":13631000.0,"CommonStockValue_0_Q1_USD":8000.0,"LongTermNotesPayable_0_Q1_USD":14907000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":-275000.0,"InvestmentIncomeNet_1_Q1_USD":12000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-1162000.0,"CostsAndExpenses_1_Q1_USD":27570000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-78000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":3121000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":1523000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":209378000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":7169000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":619530000.0,"Liabilities_0_Q1_USD":159632000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":646000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1279000.0,"RepaymentsOfNotesPayable_1_Q1_USD":2083000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-650000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3086000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-17359000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":76071017.0,"InventoryWorkInProcess_0_Q1_USD":402000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_1_Q1_shares":5769232.0,"LiabilitiesCurrent_0_Q1_USD":27437000.0,"AccountsPayableCurrent_0_Q1_USD":4152000.0,"NonoperatingIncomeExpense_1_Q1_USD":23349000.0,"InterestExpense_1_Q1_USD":1679000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":211142000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4000000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":1197000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":699000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q1_USD":91000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q1_USD":-20817000.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_1_Q1_shares":5405457.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":10000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":7527000.0,"AmortizationOfFinancingCosts_1_Q1_USD":1132000.0,"IncreaseDecreaseInDerivativeLiabilities_1_Q1_USD":25016000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.24,"CommonStockSharesOutstanding_0_Q1_shares":76236710.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":7342000.0,"OperatingIncomeLoss_1_Q1_USD":-20228000.0,"NotesPayableCurrent_0_Q1_USD":8290000.0,"InventoryNet_0_Q1_USD":1123000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":243040000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":3237000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"DerivativeLiabilities_0_Q1_USD":73297000.0,"DerivativeLiabilitiesNoncurrent_0_Q1_USD":73297000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1421000.0,"ProfitLoss_1_Q1_USD":3121000.0,"StockholdersEquity_0_Q1_USD":83408000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":12000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":158000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-536130000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-18679000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":1379000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3086000.0,"InterestOnConvertibleDebtNetOfTax_1_Q1_USD":1078000.0,"Ticker":"OCUL","CIK":"1393434","name":"OCULAR THERAPEUTIX, INC","OfficialName":"Ocular Therapeutix Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"305481557.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]